Page 32 - GPD-3-2

Gene & Protein in Disease Review of CAR-T in ADs

doi: 10.1016/j.jaut.2009.09.008 15. Mouat IC, Goldberg E, Horwitz MS. Age-associated B cells
in autoimmune diseases. Cell Mol Life Sci. 2022;79(8):402.
4. Walsh SJ, Rau LM. Autoimmune diseases: A leading cause of
death among young and middle-aged women in the United doi: 10.1007/s00018-022-04433-9
States. Am J Public Health. 2000;90(9):1463-1466. 16. Takeuchi Y, Hirota K, Sakaguchi S. Impaired T cell receptor
doi: 10.2105/ajph.90.9.1463 signaling and development of T cell-mediated autoimmune
arthritis. Immunol Rev. 2020;294(1):164-176.
5. Eggenhuizen PJ, Ng BH, Ooi JD. Treg enhancing therapies to
treat autoimmune diseases. Int J Mol Sci. 2020;21(19):7015. doi: 10.1111/imr.12841
doi: 10.3390/ijms21197015 17. Lee JY, Hall JA, Kroehling L, et al. Serum amyloid a proteins
induce pathogenic Th17 cells and promote inflammatory
6. Anaya JM. The diagnosis and clinical significance of
polyautoimmunity. Autoimmun Rev. 2014;13(4-5):423-426. disease. Cell. 2020;180(1):79-91.e16.
doi: 10.1016/j.cell.2019.11.026
doi: 10.1016/j.autrev.2014.01.049
18. Zhu H, Li R, Da Z, et al. Remission assessment of rheumatoid
7. Kretschmann S, Völkl S, Reimann H, et al. Successful arthritis in daily practice in China: A cross-sectional
generation of CD19 chimeric antigen receptor T cells from observational study. Clin Rheumatol. 2018;37(3):597-605.
patients with advanced systemic lupus erythematosus.
Transplantat Cell Ther. 2023;29(1):27-33. doi: 10.1007/s10067-017-3850-z
doi: 10.1016/j.jtct.2022.10.004 19. Hellesen A, Bratland E, Husebye ES. Autoimmune Addison’s
disease - an update on pathogenesis. Ann Endocrinol (Paris).
8. Aragón CC, Ruiz-Ordoñez I, Quintana JH, et al. Clinical 2018;79(3):157-163.
characterization, outcomes, and prognosis in patients with
systemic lupus erythematosus admitted to the intensive care doi: 10.1016/j.ando.2018.03.008
unit. Lupus. 2020;29(9):1133-1139. 20. Sadeqi Nezhad M, Seifalian A, Bagheri N, Yaghoubi S,
doi: 10.1177/0961203320935176 Karimi MH, Adbollahpour-Alitappeh M. Chimeric antigen
receptor based therapy as a potential approach in
9. Quintero OL, Rojas-Villarraga A, Mantilla RD, Anaya JM. autoimmune diseases: How close are we to the treatment?
Autoimmune diseases in the intensive care unit. An update. Front Immunol. 2020;11:603237.
Autoimmun Rev. 2013;12(3):380-395.
doi: 10.3389/fimmu.2020.603237
doi: 10.1016/j.autrev.2012.06.002
21. Yasunaga M. Antibody therapeutics and immunoregulation
10. Matute-Blanch C, Montalban X, Comabella M. Multiple in cancer and autoimmune disease. Semin Cancer Biol.
sclerosis, and other demyelinating and autoimmune 2020;64:1-12.
inflammatory diseases of the central nervous system. Handb
Clin Neurol. 2017;146:67-84. doi: 10.1016/j.semcancer.2019.06.001
doi: 10.1016/b978-0-12-804279-3.00005-8 22. Reincke SM, von Wardenburg N, Homeyer MA, et al.
Chimeric autoantibody receptor T cells deplete NMDA
11. Feng PH, Lin SM, Yu CT, et al. Inadequate antimicrobial receptor-specific B cells. Cell. 2023;186(23):5084-5097.e18.
treatment for nosocomial infection is a mortality risk
factor for systemic lupus erythematous patients admitted to doi: 10.1016/j.cell.2023.10.001
intensive care unit. Am J Med Sci. 2010;340(1):64-68. 23. Selewski DT, Shah GV, Mody RJ, Rajdev PA, Mukherji SK.
doi: 10.1097/MAJ.0b013e3181e0ef9b Rituximab (Rituxan). Am J Neuroradiol. 2010;31(7):1178-1180.
12. Rose NR. Prediction and prevention of autoimmune disease doi: 10.3174/ajnr.A2142
in the 21 century: A review and preview. Am J Epidemiol. 24. Flugel CL, Majzner RG, Krenciute G, et al. Overcoming
st
2016;183(5):403-406. on-target, off-tumour toxicity of CAR T cell therapy for
doi: 10.1093/aje/kwv292 solid tumours. Nat Rev Clin Oncol. 2023;20(1):49-62.
13. Yasuda K, Takeuchi Y, Hirota K. The pathogenicity of doi: 10.1038/s41571-022-00704-3
Th17 cells in autoimmune diseases. Semin Immunopathol. 25. Zhang X, Zhu L, Zhang H, Chen S, Xiao Y. CAR-T cell therapy
2019;41(3):283-297. in hematological malignancies: Current opportunities and
doi: 10.1007/s00281-019-00733-8 challenges. Front Immunol. 2022;13:927153.
14. Xiao ZX, Miller JS, Zheng SG. An updated advance of doi: 10.3389/fimmu.2022.927153
autoantibodies in autoimmune diseases. Autoimmun Rev. 26. Dominguez G. The CART gene: Structure and regulation.
2021;20(2):102743. Peptides. 2006;27(8):1913-1918.
doi: 10.1016/j.autrev.2020.102743 doi: 10.1016/j.peptides.2006.01.025

Volume 3 Issue 2 (2024) 11 doi: 10.36922/gpd.2851